EnglishGermanHebrewKorean
  • CEO

Plants

Pan-Global Specialized Manufacturing Capabilities

Global

Global Plants

Maximizing our accumulated knowhow,
we have acquired or built plants in strategic
geographical locations that better enable us
to address the local markets' needs.

IndonesiaSurabaya Plant

Surabaya
Feature
Dedicated for Biological products (EPO, EGF,
Somatropin)
Independent production lines preventing cross-
contamination
HALAL certified process management from drug
substance to finished products
Capacity: Prefilled Syringe (4M)
Area
2,484 m2 (26,737 ft2)
Manufacturing Products
Biopharmaceutical Products
(EPO, EGF, hGH, BMP)

ChinaHaifa Plant

Liaoning
Feature
Closed system throughout the production process
BIN System based transfer and handling
Unmanned ingredient transfer using line and pump
Capacity: Oral Liquid (200M pouch, 30M bottle)
Area
9,586 m2 (103,182 ft2)
Manufacturing Products
Liquid for oral administration

ChinaSichuan Plant

Sichuan
Feature
Top gall bladder-related production technology
UDCA intermediate production
API & CDCA (Chenodeoxycholic acid)
Area
10,000 m2 (107,639 ft2)
Manufacturing Products
Chenodeoxycholic acid, crude Cholic acid

Total Capacity per Year

Total Capacity per Year
Type Quantity
Tablet 6.7 Billion
Capsule 205 Million
Vial 70 Million
Bottle 102 Million
Pouch 130 Million
Syringe 5.6 Million
Bag 0.5 Million
Ampoule 0.1 Billion
Kit 7 Million